Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Andrew Strahs"'
Autor:
Robert J. Pignolo, Geneviève Baujat, Matthew A. Brown, Carmen De Cunto, Maja Di Rocco, Edward C. Hsiao, Richard Keen, Mona Al Mukaddam, Kim Hanh Le Quan Sang, Andrew Strahs, Rose Marino, Frederick S. Kaplan
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100607- (2020)
Externí odkaz:
https://doaj.org/article/f36899907b7e499e9d2620de71c717ca
Autor:
Robert J. Pignolo, Geneviève Baujat, Matthew A. Brown, Carmen De Cunto, Maja Di Rocco, Edward C. Hsiao, Richard Keen, Mona Al Mukaddam, Andrew Strahs, Donna R. Grogan, Rose Marino, Frederick S. Kaplan
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100609- (2020)
Externí odkaz:
https://doaj.org/article/800db7cf5eef47ba9acfef2c1a8b1db7
Autor:
Robert J Pignolo, Edward C Hsiao, Mona Al Mukaddam, Geneviève Baujat, Staffan K Berglund, Matthew A Brown, Angela M Cheung, Carmen De Cunto, Patricia Delai, Nobuhiko Haga, Peter Kannu, Richard Keen, Kim-Hanh Le Quan Sang, Edna E Mancilla, Rose Marino, Andrew Strahs, Frederick S Kaplan
Publikováno v:
Future Rare Diseases. 3
What is this summary about? This is a plain language summary of an article originally published in the Journal of Bone and Mineral Research. People with fibrodysplasia ossificans progressiva (FOP) become physically disabled over time as new bone form
Autor:
Robert J. Pignolo, Edward C. Hsiao, Mona Al Mukaddam, Geneviève Baujat, Staffan K. Berglund, Matthew A. Brown, Angela M. Cheung, Carmen De Cunto, Patricia Delai, Nobuhiko Haga, Peter Kannu, Richard Keen, Kim‐Hanh Le Quan Sang, Edna E. Mancilla, Rose Marino, Andrew Strahs, Frederick S. Kaplan
Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare, severely disabling genetic disorder of progressive heterotopic ossification (HO). The single-arm, open-label, phase 3 MOVE trial (NCT03312634) assessed efficacy and safety of palovarotene,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::492896d9f94932c067c4d1dfb7363b11
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-204678
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-204678
Autor:
null Robert J. Pignolo, null Edward C. Hsiao, null Mona Al Mukaddam, null Geneviève Baujat, null Staffan K. Berglund, null Matthew A. Brown, null Angela M. Cheung, null Carmen De Cunto, null Patricia Delai, null Nobuhiko Haga, null Peter Kannu, null Richard Keen, null Kim‐Hanh Le Quan Sang, null Edna E. Mancilla, null Rose Marino, null Andrew Strahs, null Frederick S. Kaplan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48116c305a70e6443e123fdf0b160e3e
https://doi.org/10.1002/jbmr.4762/v2/response1
https://doi.org/10.1002/jbmr.4762/v2/response1
Autor:
Robert J. Pignolo, Geneviève Baujat, Matthew A. Brown, Carmen De Cunto, Edward C. Hsiao, Richard Keen, Mona Al Mukaddam, Kim-Hanh Le Quan Sang, Amy Wilson, Rose Marino, Andrew Strahs, Frederick S. Kaplan
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics. 24(12)
We report the first prospective, international, natural history study of the ultra-rare genetic disorder fibrodysplasia ossificans progressiva (FOP). FOP is characterized by painful, recurrent flare-ups, and disabling, cumulative heterotopic ossifica
Autor:
Andrew Strahs, M Al Mukaddam, Rose Marino, Edward C. Hsiao, M Di Rocco, Robert J. Pignolo, K-H Le Quan Sang, C Stockklausner, Matthew A. Brown, F.S. Kaplan, C De Cunto, Geneviève Baujat, Richard Keen
Publikováno v:
Osteologie.
Autor:
Andrew Strahs, Frederick S. Kaplan, Matthew A. Brown, Cunto Carmen De, Robert J. Pignolo, Geneviève Baujat, Rocco Maja Di, Mona Al Mukaddam, Rose Marino, Quan Sang Kim-Hanh Le, Richard Keen, Edward C. Hsiao
Publikováno v:
Endocrine Abstracts.
Autor:
Richard Keen, Maja Di Rocco, Mona Al Mukaddam, Geneviève Baujat, Robert J. Pignolo, Andrew Strahs, Rose Marino, Matthew A. Brown, Frederick S. Kaplan, Carmen De Cunto, Edward C. Hsiao, Kim-Hanh Le Quan Sang
Publikováno v:
Journal of the Endocrine Society
Background: FOP is an ultra-rare, severely disabling genetic disorder characterized by episodic flare-ups and heterotopic ossification (HO) leading to restricted movement, physical disability, and early death. FOP may initially be misdiagnosed in ~90
Autor:
Akshay Vaishnaw, Peter L.J. Wijngaard, Amy Simon, Brian Bettencourt, Kevin Fitzgerald, Jay D. Horton, Chamikara Fernando, Jorg Taubel, Anna Borodovsky, Ashley Brooks, Valerie A. Clausen, Andrew Strahs, Robert S. Kauffman, David Kallend, Suellen White
Publikováno v:
New England Journal of Medicine. 376:41-51
BackgroundInclisiran (ALN-PCSsc) is a long-acting RNA interference (RNAi) therapeutic agent that inhibits the synthesis of proprotein convertase subtilisin–kexin type 9 (PCSK9), a target for the lowering of low-density lipoprotein (LDL) cholesterol